|
CH503559A
(de)
|
1969-02-26 |
1971-02-28 |
Arx Paul Von |
Vorrichtung an Tafelschere zum Schneiden nach Markierungen, unter ständiger Beobachtung des Schnittes
|
|
GB9119920D0
(en)
|
1991-09-18 |
1991-10-30 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB9624482D0
(en)
|
1995-12-18 |
1997-01-15 |
Zeneca Phaema S A |
Chemical compounds
|
|
DE69720965T2
(de)
|
1996-02-13 |
2004-02-05 |
Astrazeneca Ab |
Chinazolinderivate und deren verwendung als vegf hemmer
|
|
NZ331191A
(en)
|
1996-03-05 |
2000-03-27 |
Zeneca Ltd |
4-anilinoquinazoline derivatives and pharmaceutical compositions thereof
|
|
GB9718972D0
(en)
|
1996-09-25 |
1997-11-12 |
Zeneca Ltd |
Chemical compounds
|
|
GB9714249D0
(en)
|
1997-07-08 |
1997-09-10 |
Angiogene Pharm Ltd |
Vascular damaging agents
|
|
GB9900334D0
(en)
|
1999-01-07 |
1999-02-24 |
Angiogene Pharm Ltd |
Tricylic vascular damaging agents
|
|
GB9900752D0
(en)
|
1999-01-15 |
1999-03-03 |
Angiogene Pharm Ltd |
Benzimidazole vascular damaging agents
|
|
PT1154774E
(pt)
|
1999-02-10 |
2005-10-31 |
Astrazeneca Ab |
Derivados de quinazolina como inibidores de angiogenese
|
|
AU2001258628A1
(en)
|
2000-05-31 |
2001-12-11 |
Astrazeneca Ab |
Indole derivatives with vascular damaging activity
|
|
UA73993C2
(uk)
|
2000-06-06 |
2005-10-17 |
Астразенека Аб |
Хіназолінові похідні для лікування пухлин та фармацевтична композиція
|
|
MXPA02012905A
(es)
|
2000-07-07 |
2004-07-30 |
Angiogene Pharm Ltd |
Derivados de colquinol como agentes de dano vascular..
|
|
MXPA02012903A
(es)
|
2000-07-07 |
2004-07-30 |
Angiogene Pharm Ltd |
Derivados de colquinol como inhibidores de angiogenesis.
|
|
WO2002085309A2
(en)
|
2001-04-24 |
2002-10-31 |
Epigenesis Pharmaceuticals, Inc. |
Composition, formulations & kits for treatment of respiratory & lung disease with anti-sense oligonucleotides & a bronchodilating agent
|
|
SE0102808D0
(sv)
|
2001-08-22 |
2001-08-22 |
Astrazeneca Ab |
New compounds
|
|
JP2004002826A
(ja)
|
2002-04-24 |
2004-01-08 |
Sankyo Co Ltd |
高分子イミダゾピリジン誘導体
|
|
EP1797077B1
(en)
|
2004-09-24 |
2012-02-15 |
AstraZeneca AB |
Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof i
|
|
MX2007013595A
(es)
|
2005-05-04 |
2008-01-24 |
Renovis Inc |
Compuestos heterociclicos fusionados y composiciones y usos de estos.
|
|
DE102006028862A1
(de)
|
2006-06-23 |
2007-12-27 |
Merck Patent Gmbh |
3-Amino-imidazo[1,2-a]pyridinderivate
|
|
US20090099195A1
(en)
|
2007-05-08 |
2009-04-16 |
Astrazeneca Ab |
Therapeutic Compounds 570
|
|
JP5608655B2
(ja)
|
2008-09-18 |
2014-10-15 |
エヴォテック アーゲー |
Ｐ２ｘ３受容体活性のモジュレーター
|
|
IN2012DN03391A
(https=)
|
2009-11-18 |
2015-10-23 |
Astrazeneca Ab |
|
|
WO2012158117A1
(en)
*
|
2011-05-17 |
2012-11-22 |
Astrazeneca Ab |
Combination therapies for treating pain
|
|
JP5893135B2
(ja)
|
2011-06-28 |
2016-03-23 |
ビボゾーン インコーポレイテッド |
多重ターゲッティングの相乗効果を誘発する有効物質の組合せ及びその用途
|
|
DK3381917T3
(da)
|
2013-01-31 |
2021-10-18 |
Bellus Health Cough Inc |
Imidazopyridinforbindelser og anvendelser deraf
|
|
EP3033245A1
(en)
|
2013-08-15 |
2016-06-22 |
Volvo Truck Corporation |
Method and arrangement for balancing an energy storage system
|
|
AU2014308606B2
(en)
|
2013-08-23 |
2017-08-03 |
Afferent Pharmaceuticals Inc. |
Diaminopyrimidine P2X3 and P2X 2/3 receptor modulators for treatment of acute, sub-acute or chronic cough
|
|
EP3230281B1
(en)
*
|
2014-12-09 |
2021-05-26 |
Bayer Aktiengesellschaft |
1,3-thiazol-2-yl substituted benzamides
|
|
DK3355889T3
(da)
|
2015-09-29 |
2023-05-15 |
Afferent Pharmaceuticals Inc |
Diaminopyrimidin-p2x3- og p2x2/3-receptormodulatorer til anvendelse i behandling af hoste
|
|
US9907795B2
(en)
*
|
2016-01-08 |
2018-03-06 |
Nerre Therapeutics Limited |
Method of treatment of chronic cough administering orvepitant in combination with other therapeutic agents
|
|
WO2017160569A1
(en)
|
2016-03-14 |
2017-09-21 |
Afferent Pharmaceuticals Inc. |
Pyrimidines and variants thereof, and uses therefor
|
|
KR20240095481A
(ko)
|
2016-03-17 |
2024-06-25 |
세다르스-신나이 메디칼 센터 |
Rnaset2를 통한 염증성 장 질환의 진단 방법
|
|
RU2019112740A
(ru)
|
2016-09-30 |
2020-11-02 |
АСАНА БАЙОСАЙЕНСИЗ, ЭлЭлСи |
P2x3 и/или p2x2/3 соединения и способы
|
|
US10111883B1
(en)
|
2017-09-18 |
2018-10-30 |
Bellus Health Cough Inc. |
Selective P2X3 modulators
|
|
CN108904507A
(zh)
*
|
2018-02-11 |
2018-11-30 |
赖英杰 |
P2x3受体调节剂苯并咪唑化合物在制备抗呼吸疾病药物中的应用
|
|
HRP20250864T1
(hr)
*
|
2018-11-13 |
2025-09-26 |
Glaxosmithkline Intellectual Property (No. 3) Limited |
Kristalni oblici p2x3 modulatora metil (s)‑2‑((2‑(2,6‑difluoro‑4‑(metilkarbamoil)fenil)‑7‑metilimidazo[1,2‑a] piridin‑3‑il)metil)morfolin‑4‑karboksilata
|
|
WO2020112890A1
(en)
|
2018-11-29 |
2020-06-04 |
Cedars-Sinai Medical Center |
Rnaset2 compositions and methods of treatment therewith
|
|
KR102797127B1
(ko)
|
2018-12-29 |
2025-04-21 |
우한 크리에이터나 사이언스 앤드 테크놀로지 컴퍼니, 리미티드 |
헤테로고리계 화합물, 중간체, 이의 제조 방법 및 용도
|
|
JP7578602B2
(ja)
|
2019-02-25 |
2024-11-06 |
グラクソスミスクライン、インテレクチュアル、プロパティー、（ナンバー３）、リミテッド |
Ｐ２ｘ３修飾薬での治療
|
|
CN115427419B
(zh)
|
2020-02-14 |
2026-04-21 |
葛兰素史密斯克莱知识产权(第3号)有限公司 |
P2x3拮抗剂的制备
|
|
EP4103564A4
(en)
|
2020-02-14 |
2024-05-01 |
GlaxoSmithKline Intellectual Property (No.3) Limited |
P2X3 MODULATORS
|